about
Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor SyndromeMultiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials.Vitamin D treatment in primary hyperparathyroidism.Sternotomy for substernal goiter: retrospective study of 52 operations.Understanding coupling between bone resorption and formation: are reversal cells the missing link?Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study.Increased presence of capillaries next to remodeling sites in adult human cancellous bone.Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism.No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial.Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism.Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR).Osteoblast recruitment routes in human cancellous bone remodeling.PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.High expression of organic cation transporter 3 in human BAT-like adipocytes. Implications for extraneuronal norepinephrine uptake.The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene.Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study.Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled TrialThe effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trialPrimary hyperparathyroidism: intraoperative PTH-measurements[Study of the quality of colonoscopies]The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled studyVitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialCorrelation between absence of bone remodeling compartment canopies, reversal phase arrest, and deficient bone formation in post-menopausal osteoporosisEffects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled TrialCoordination of Fusion and Trafficking of Pre-osteoclasts at the Marrow-Bone Interface
P50
Q37281220-277F1786-CAB1-470E-B23C-460E55A21F2AQ37319319-1B4223A3-37B1-499D-A209-53CB0FFA2819Q37567584-8CBDD5E3-31EB-465F-8D24-A1F3DF8B9FC3Q37869509-08AC2B74-79AE-4FD7-B627-3655DEDC467DQ38359437-F037869F-A3E4-4333-930B-6EE11218E524Q43405568-C3A5CA68-1395-4A11-8D83-1D35795BBCC5Q43477256-7D94C8E6-4F12-464D-8A46-326C7E9529BEQ45881370-3BE641B6-8EC3-4E38-9FDA-208600ACBFF5Q47829069-815654D5-7D6F-48DE-8CB9-5B3F8513832EQ48050902-CF72F39A-1B5D-4B93-B442-131CE54F468DQ48081325-1BAD46C3-3E77-4855-A9C2-CA3386B8E6BEQ48156628-F2D96FFC-E8F6-4EE1-8759-9CDBA7B870BCQ48225793-6333FFC5-4D9A-49B3-9D16-08EE0635BE65Q50481118-52DFBE60-52B3-41A5-9011-ACCD73C41722Q51221582-B49E87ED-E415-49C0-A0C4-1DCA81F5B91EQ51227859-275DCAB2-67F9-49F3-901F-77FB25C4548FQ51640737-929F9F0C-C62A-4984-9086-CFED3175C249Q52885465-884821BE-7363-4ACE-8F5E-BE06556D37DCQ53063892-901A517A-6AEA-42FB-AC74-E459D9110B75Q57183252-A49B8A64-94E7-424A-8A57-751B4E21EF9AQ60585716-E146F3D1-5BF0-4333-92DC-CD1AD8B19F6CQ80022553-DB4917D5-E6C6-4258-8F93-935FFF0E3EA9Q81483294-2B8CC649-8A36-44E1-A3AE-39B21F0EE553Q84578369-50714ADB-4615-4DEB-942C-0A6440E56622Q87095726-F24ECE6E-0FA2-4C34-8615-EF3B48202BBDQ87255009-5C22AE79-F1C7-4E23-BCE3-C7047DCACDCEQ89184059-B26F1FC5-7706-46F1-86D2-F887E0532557Q93005366-F8B24AA9-5BC9-4287-B9F9-7AA346850791
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lars Rolighed
@ast
Lars Rolighed
@en
Lars Rolighed
@es
Lars Rolighed
@nl
Lars Rolighed
@sl
type
label
Lars Rolighed
@ast
Lars Rolighed
@en
Lars Rolighed
@es
Lars Rolighed
@nl
Lars Rolighed
@sl
prefLabel
Lars Rolighed
@ast
Lars Rolighed
@en
Lars Rolighed
@es
Lars Rolighed
@nl
Lars Rolighed
@sl
P106
P31
P496
0000-0002-0757-298X